Product Summary
Ibrutinib (CAS 936563-96-1, PCI-32765) is first-in-class oral irreversible BTK inhibitor API for B-cell lymphoma treatment, compliant with USP/EP specification. Our pharmaceutical grade raw powder with ≥99% HPLC purity is available from gram to bulk kg packing for formulation and scientific research...
GMP factory supply Ibrutinib Powder high purity CAS 936563-96-1 Ibrutinib
Basic Properties
Trading Properties
GMP Ibrutinib Powder high purity
,Ibrutinib API CAS 936563-96-1
,Pharmaceutical grade Ibrutinib Powder
CAS No. 936563-96-1
Synonyms PCI-32765; Imbruvica;
Chemical Name (R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
Appearance White to off-white crystalline powder
Purity ≥99.0% HPLC(USP/EP Pharma Grade)
Melting Point 153~158℃
Density 1.34 g/cm³
Solubility Soluble in DMSO,Methanol; Practically insoluble in water(<1mg/mL)
Storage Sealed, -20℃ away from light; DMSO liquid stored -20℃ ≤3 months
Application 1. Oral API for anti-B-cell hematological malignancies
2. Indications: Mantle Cell Lymphoma(MCL), CLL/SLL, Waldenström’s Macroglobulinemia(WM), Marginal Zone Lymphoma
3. Lab research BTK inhibitor reagent
Standard USP, EP, In-house Pharmacopoeia Standard

Please use our online inquiry contact form below if you have any questions, our team will get back to you as soon as possible.